Skip to main content

Scynexis Inc

SCYX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001178253

No open-market purchases or sales by Scynexis Inc insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Scynexis Inc changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of SCYX: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders4440−4
Shares16.3M15.3M−968.1K (−5.9%)
Value$39.1M$23.9M−$15.2M (−38.8%)

New holders (4)

Institutions that held Scynexis Inc at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to SCYX in Q4 2022
InstitutionSharesValue% of portfolio
Bleakley Financial Group, LLC20,000$31.2K0.00%
Renaissance Technologies LLC11,000$17.0K0.00%
Belpointe Asset Management LLC3,980$6.21K0.00%
Cornerstone Planning Group LLC300$4920.00%

Sold out (8)

Institutions that held Scynexis Inc at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of SCYX in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
UBS Oconnor LLC535,670$1.29M
Virtu Financial LLC31,801$76.0K
Jane Street Group, LLC24,870$60.0K
Ameriprise Financial Inc22,440$54.0K
Park Avenue Securities LLC14,000$34.0K
HighTower Advisors, LLC10,030$24.0K
Rockefeller Capital Management L.P.2,035$4.00K
Cutler Group LP250$0